C
CRSP
Crispr Therapeut
51.22
-0.50-0.97%After Hours: 51.50 +0.28 +0.55%19:55 04/10 EDT
OPEN/PREV CLOSE51.75/51.72
TODAY RANGE49.50-52.22
VOL871.73K
MARKET CAP4.92B
52 WEEK RANGE30.04-78.48
AVG VOL (3M)1.87M
% TURNOVER0.91%
TURNOVER--
P/E (TTM)-7.9195
% RANGE5.26%
EPS(TTM)-6.4676
P/E(FORWARD)-10.0159
P/B2.556
BVPS20.04
DIVIDEND--
P/S1,399.45
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.68B
SHARES OUTSTANDING95.99M
NEXT EARNINGS05/04-05/08
FREE FLOAT91.29M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Undercovered Dozen: CVR Energy, Greystone Housing, Conagra Brands, And More
Seeking Alpha·04/03 18:25
Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM
Seeking Alpha·04/01 16:43
A Turning Point For Crispr Therapeutics As Commercial Growth Accelerates
Seeking Alpha·03/31 12:30
I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations
TipRanks·03/30 13:35
Mizuho Securities Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP)
TipRanks·03/26 17:50
Cathie Wood’s ARK Invest Dumps $2.1M Worth of META Shares; Stock Sinks
NASDAQ·03/20 11:58
Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag?
TipRanks·03/17 10:56
Crispr Therapeutics price target raised to $110 from $105 at Piper Sandler
TipRanks·03/16 20:34
Crispr Therapeutics Completes $600 Million Convertible Notes Offering
Seeking Alpha·03/16 11:05
Cathie Wood's weekly recap: adds JOBY, CRSP, TEM, sells TER, TXG, CRCL
Same Industry
Name/Symbol
Change%
Price